Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $5.3 Million - $6.18 Million
-98,772 Closed
0 $0
Q3 2021

Oct 13, 2021

SELL
$59.17 - $69.31 $2.76 Million - $3.23 Million
-46,616 Reduced 32.06%
98,772 $5.84 Million
Q2 2021

Jul 14, 2021

BUY
$61.91 - $67.42 $93,174 - $101,467
1,505 Added 1.05%
145,388 $9.72 Million
Q1 2021

Apr 23, 2021

BUY
$59.34 - $66.74 $189,057 - $212,633
3,186 Added 2.26%
143,883 $9.08 Million
Q4 2020

Jan 29, 2021

BUY
$57.74 - $65.43 $307,927 - $348,938
5,333 Added 3.94%
140,697 $8.73 Million
Q3 2020

Oct 14, 2020

BUY
$57.43 - $63.64 $3.34 Million - $3.7 Million
58,108 Added 75.21%
135,364 $8.16 Million
Q2 2020

Aug 06, 2020

BUY
$54.82 - $64.09 $69,018 - $80,689
1,259 Added 1.66%
77,256 $4.59 Million
Q1 2020

Apr 28, 2020

SELL
$46.4 - $67.43 $79,251 - $115,170
-1,708 Reduced 2.2%
75,997 $4.17 Million
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $301,165 - $392,842
-6,120 Reduced 7.3%
77,705 $4.92 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $3.59 Million - $4.25 Million
83,825 New
83,825 $4.86 Million
Q2 2019

Aug 12, 2019

SELL
$44.62 - $49.34 $178,881 - $197,804
-4,009 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $5,820 - $6,940
-129 Reduced 3.12%
4,009 $191,000
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $201,768 - $261,645
4,138 New
4,138 $215,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bruderman Asset Management, LLC Portfolio

Follow Bruderman Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruderman Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruderman Asset Management, LLC with notifications on news.